Journal of Organic Chemistry, volume 62, issue 11, pages 3440-3448
Practical, Stereoselective Synthesis of Palinavir, a Potent HIV Protease Inhibitor
Pierre L Beaulieu
1
,
Pierre Lavallée
1
,
Abraham
1
,
Paul C. Anderson
1
,
Colette Boucher
1
,
YVES BOUSQUET
1
,
Jean-Simon Duceppe
1
,
James Gillard
1
,
Vida Gorys
1
,
Chantal Grand-Maître
1
,
Louis Grenier
1
,
Yvan Guindon
1
,
Ingrid Guse
1
,
Louis Plamondon
1
,
François Soucy
1
,
Serge Valois
1
,
Dominik Wernic
1
,
Christiane Yoakim
1
1
Bio-Méga Research Division, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval (Québec), Canada, H7S 2G5
|
Publication type: Journal Article
Publication date: 1997-05-01
Journal:
Journal of Organic Chemistry
scimago Q2
SJR: 0.724
CiteScore: 6.2
Impact factor: 3.3
ISSN: 00223263, 15206904
Organic Chemistry
Abstract
Palinavir is a potent peptidomimetic-based HIV protease inhibitor. We have developed a highly convergent and stereoselective synthesis which is amenable to the preparation of multikilogram quantities of this compound. The synthetic sequence proceeds in 24 distinct chemical steps (with several integrated, multistep operations) from commercially available starting materials. No chromatographies are required throughout the process, and the final product is purified by crystallization of its dihydrochloride salt to >99% homogeneity.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.